TransMedics Group Inc (TMDX) Stock Forecast & Price Target
TransMedics Group Inc · NASDAQ
$76.20+1.93 (+2.59%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 10 firms covering TransMedics Group Inc, 7 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $80.00 to $175.00 (about 2.2x), a sign of real disagreement on valuation. The average target of $128.00 sits 68% above the current $76.20. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 6 to 7 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.39 next quarter toward $2.86 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 ratings
Moderate Buy
Strong Buy00%
Buy770%
Hold330%
Sell00%
Strong Sell00%
Based on 10 analysts giving stock ratings to TransMedics Group Inc.
As of Jul, 7 of 10 firms rate TMDX a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
TMDX EPS & revenue forecast
EPS · NEXT QUARTER
$0.39
Range $0.28 – $0.57 · 8 analysts · -41% YoY
Next period, 8 analysts expect TransMedics Group Inc to earn $0.39 a share (range $0.28 – $0.57), versus $0.66 a year earlier. Full-year consensus is $1.76, growing to $2.86 the year after.
REVENUE · NEXT QUARTER
$175.7M
Range $172.0M – $184.6M · 8 analysts · +22% YoY
Revenue is expected to reach $175.7M (range $172.0M – $184.6M), +22.2% year-over-year. Full-year consensus is $733.0M, rising to $867.8M next year.
Top analysts covering TransMedics Group Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TMDX.
#1
William Plovanic
Canaccord Genuity · Rank #190
Buy
$124.00+62.7% to target
Overall win rate
36%
+ Follow
#2
Mike Matson
Needham · Rank #204
Buy
$142.00+86.3% to target
Overall win rate
31%
+ Follow
#3
Matt O'Brien
Piper Sandler · Rank #356
Buy
$120.00+57.5% to target
Overall win rate
25%
+ Follow
#4
TS
Thomas Stephan
Stifel
Hold
$80.00+5.0% to target
Coverage
—
+ Follow
#5
DM
Daniel Markowitz
Evercore ISI Group
Buy
$90.00+18.1% to target
Coverage
—
+ Follow
TMDX stock forecast FAQ
What is TMDX's average 12-month price target?+
The 10 analysts with a live target average $128.00 for TransMedics Group Inc over the next 12 months, ranging from a $175.00 high to a $80.00 low.
Is TMDX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 10 analyst ratings, 7 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for TMDX?+
The Street-high target is $175.00 (Oppenheimer), and the Street-low is $80.00 (Stifel). The average of all 10 active targets is $128.00.
How many Wall Street analysts cover TMDX?+
10 analysts have an active rating on TransMedics Group Inc, and 10 firms carry a live 12-month price target.
Who is the most accurate analyst covering TMDX?+
Among analysts who currently cover TMDX, William Plovanic of Canaccord Genuity has the strongest overall Quantellect track record (Rank #190). Their current call is Buy with a $124.00 target.
What is TransMedics Group Inc's projected EPS for next quarter?+
The consensus estimate is $0.39 per share (range $0.28 – $0.57) across 8 analysts. Full-year EPS is projected at $1.76, rising to $2.86 the following year.
How much revenue is TransMedics Group Inc expected to report next quarter?+
Consensus revenue is $175.7M (range $172.0M – $184.6M). Full-year revenue is projected at $733.0M, growing to $867.8M next year.
Have analysts been upgrading or downgrading TMDX lately?+
As of Jul, 7 of 10 firms rate TMDX a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TMDX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
